ROLE OF METABOLIC DYSFUNCTION IN ADVANCED PROSTATE CANCER
RESEARCHER PROFILE
Dr Jennifer Gunter (Filmed March 2024)
Senior Research Associate (Cancer Metabolism),
Australia Prostate Cancer Research Centre – Queensland (APCRC-Q) & Group Leader, Cancer Metabolism Group,
Translational Research Institute (TRI),
Queensland, Australia
Dr Jennifer (Jenni) Gunter is a mid-career researcher, with a metabolic research background spanning almost 15 years. She leads a research team examining the metabolic plasticity of cancer cells with the aim of identifying therapeutic targeting strategies that extend patient survival. Jenni completed her PhD in 2005 at the Oxford Centre for Diabetes, Endocrinology and Metabolism at Oxford University.
She returned to Australia in 2006 with a University of Queensland Postdoctoral Fellowship at the UQ Diamantina Institute to pursue studies into the turnover and metabolism of adipocytes in obesity.
In 2010, Jenni joined the Institute of Health and Biomedical Innovation, at QUT to research the intersection between chronic metabolic disorders and their emerging relationship to cancer. These studies were focused on the role of insulin and the relationship between the insulin and androgen signalling axes.
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.
You Might also like
-
Gerontological physiotherapy in falls prevention and prehabilitation
Dr Rik Dawson is a gerontological physiotherapist and health leader dedicated to improving healthy ageing through evidence-based physiotherapy, digital health and health system reform. As a Postdoctoral Researcher at the Institute for Musculoskeletal Health, University of Sydney, and President of the Australian Physiotherapy Association, he combines research and policy to improve access to high quality care for older people.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
-
Dr Kelly-Anne Masterman
RESEARCH IN NEEDLE-FREE VACCINE DELIVERY SYSTEM
@ VAXXAS, BRISBANE, QUEENSLAND, AUSTRALIA